Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction
- PMID: 39501071
- PMCID: PMC11538462
- DOI: 10.1038/s41746-024-01308-0
Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction
Abstract
Coronary artery calcium (CAC) scans contain valuable information beyond the Agatston Score which is currently reported for predicting coronary heart disease (CHD) only. We examined whether new artificial intelligence (AI) applied to CAC scans can predict non-CHD events, including heart failure, atrial fibrillation, and stroke. We applied AI-enabled automated cardiac chambers volumetry and calcified plaque characterization to CAC scans (AI-CAC) of 5830 asymptomatic individuals (52.2% women, age 61.7 ± 10.2 years) in the multi-ethnic study of atherosclerosis during 15 years of follow-up, 1773 CVD events accrued. The AUC at 1-, 5-, 10-, and 15-year follow-up for AI-CAC vs. Agatston score was (0.784 vs. 0.701), (0.771 vs. 0.709), (0.789 vs. 0.712) and (0.816 vs. 0.729) (p < 0.0001 for all), respectively. AI-CAC plaque characteristics, including number, location, density, plus number of vessels, significantly improved CHD prediction in the CAC 1-100 cohort vs. Agatston Score. AI-CAC significantly improved the Agatston score for predicting all CVD events.
© 2024. The Author(s).
Conflict of interest statement
Several members of the writing group are inventors of the AI tool mentioned in this paper. M.N. is the founder of HeartLung.AI. A.P.R., T.A., D.F.Y., N.D.W., and D.L. are advisors to HeartLung.AI. C.Z. is a software engineer for HeartLung.AI. K.A. is a graduate research associate of HeartLung.AI. The remaining authors declare no competing interests.
Figures



Update of
-
AI-enabled Cardiac Chambers Volumetry and Calcified Plaque Characterization in Coronary Artery Calcium (CAC) Scans (AI-CAC) Significantly Improves on Agatston CAC Score for Predicting All Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.Res Sq [Preprint]. 2024 Jun 20:rs.3.rs-4433105. doi: 10.21203/rs.3.rs-4433105/v1. Res Sq. 2024. Update in: NPJ Digit Med. 2024 Nov 5;7(1):309. doi: 10.1038/s41746-024-01308-0. PMID: 38947043 Free PMC article. Updated. Preprint.
References
-
- Greenland, P. & Lloyd-Jones, D. M. Role of coronary artery calcium testing for risk assessment in primary prevention of atherosclerotic cardiovascular disease: a review. JAMA Cardiol.7, 219–224 (2022). - PubMed
-
- Grundy, S. M. et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. J. Am. Coll. Cardiol.73, e285–e350 (2019). - PubMed
-
- Goff, D. C. et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation129, S49–S73 (2014). - PubMed
-
- Vega, G. L., Wang, J. & Grundy, S. M. Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease. J. Clin. Lipido.16, 66–74 (2022). - PubMed
Grants and funding
- N01 HC095168/HL/NHLBI NIH HHS/United States
- 75N92020D00001/HL/NHLBI NIH HHS/United States
- N01 HC095167/HL/NHLBI NIH HHS/United States
- HHSN268201500003I/HL/NHLBI NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- N01 HC095166/HL/NHLBI NIH HHS/United States
- N01 HC095160/HL/NHLBI NIH HHS/United States
- 75N92020D00002/HL/NHLBI NIH HHS/United States
- HHSN268201500003C/HL/NHLBI NIH HHS/United States
- N01 HC095161/HL/NHLBI NIH HHS/United States
- 75N92020D00005/HL/NHLBI NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- 75N92020D00003/HL/NHLBI NIH HHS/United States
- R42 AR070713/AR/NIAMS NIH HHS/United States
- R01 HL146666/HL/NHLBI NIH HHS/United States
- UL1 TR001420/TR/NCATS NIH HHS/United States
- 75N92020D00004/HL/NHLBI NIH HHS/United States
- N01 HC095163/HL/NHLBI NIH HHS/United States
- 75N92020D00007/HL/NHLBI NIH HHS/United States
- N01 HC095162/HL/NHLBI NIH HHS/United States
- 75N92020D00006/HL/NHLBI NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
- N01 HC095164/HL/NHLBI NIH HHS/United States